The Effect of Femoral Nerve Block on Postoperative Opioid Use After Anterior Cruciate Ligament (ACL) Reconstruction

University of British Columbia30 enrolled

Overview

This study evaluates the effect of a femoral nerve block on opioid requirements following anterior cruciate ligament (ACL) reconstruction. This is a double blind, prospective randomized controlled trial.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Pain, Postoperative

Interventions

Administration of a femoral nerve block (bupivacaine HCL)PROCEDURE

See Detailed Description

Eligibility

Sex: ALLMin age: 12 YearsMax age: 17 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Schedule for primary elective anterior cruciate ligament reconstruction * Tolerance to bupivacaine * Tolerance to non-steroidal anti-inflammatory drugs (NSAIDs) * Informed consent Exclusion Criteria: * Patients who received a femoral nerve block more than 1 hour prior to surgery * Complex associated injuries or pre-existing conditions that will delay time to ambulation * Children with tibial avulsion fractures * Allergic and/or sensitive to bupivacaine and/or NSAIDs * 30% over ideal body weight * Acute ACL reconstruction (done less than 2 weeks after injury) * Pre-existing femoral nerve injury * Psychiatric patients on psychotropic agents * History of drug or alcohol dependence or recreational drug use * Refusal to provide informed consent

Locations (1)

British Columbia Children's Hospital, Department of Orthopaedics

Vancouver, British Columbia, Canada

Outcomes

Primary Outcomes

Postoperative morphine requirement

Secondary Outcomes

Pain rating

Time frame: immediately post-op

Opioid surgical time

Time frame: time from end of anaesthesia to first requirement of morphine

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.